Amgen Inc. will declare its first-ever quarterly dividend on common stock following the second quarter and anticipates an annual payout ratio of 20 percent on adjusted net income – about 27 cents per share if it had been applied to first quarter net income. It's a notable milestone not only for this mature big biotech, but a sign of the times for the sector as a whole.